Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Singular Genomics Systems Inc’s current trading price is -85.83% away from its 52-week high, while its distance from the 52-week low is 37.05%. The stock’s price range during this period has varied between $0.31 and $3.00. The company, active in the Healthcare sector, saw a trading volume of around 0.83 million for the day, considerably higher average daily volume of 0.58 million observed over the last three months.
Singular Genomics Systems Inc (OMIC) current stock price is $0.43. During the last trading session, the stock soared, reaching $0.45 after opening at $0.385. The stock’s lowest point was $0.37 before it closed at $0.40.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
Singular Genomics Systems Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $3.00 on 02/06/23, while the lowest price during the same period was $0.31 on 11/10/23.
How Financial Performance Impacts Market Capitalization
Singular Genomics Systems Inc (OMIC) has experienced a quarterly decline of -15.51% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 31.08M and boasts a workforce of 275 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.5430, with a change in price of -0.3786. Similarly, Singular Genomics Systems Inc recorded 456,490 in trading volume during the last 100 days, posting a change of -47.11%.
How OMIC’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for OMIC stands at 0.39. Similarly, the long-term debt-to-equity ratio is also 0.35.
OMIC Stock Stochastic Average
As of today, the raw stochastic average of Singular Genomics Systems Inc over the past 50 days is 35.67%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 35.67%. Additionally, the Stochastic %K and %D values for the company were 26.77% and 20.91%, respectively, over the past 20 days.
OMIC Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded a decrease of -78.86%. However, over the last six months, the performance has been stronger by -46.85%. The price of OMIC increased 18.06% over the last 30 days. And in the last five days, it has fallen by -19.23%.
